Table III. Levels of MPs and procoagulant activity in relation to cytoreductive treatment in MPN patients.
1Values denote median and interquartile range. PMPs: Platelet microparticles; RMPs: erythrocyte microparticles; MP-activity: procoagulant activity of microparticles; n-s: number of samples. *p<0.05.